Betnovate scalp application (PGD) 100ml
Betnovate scalp application (PGD) 100ml
Are you struggling with an itchy, irritated scalp due to atopic eczema? Look no further. Betnovate scalp application, a widely acclaimed treatment, could be the relief you're seeking. Recognised as a dependable solution for dermatoses of the scalp, Betnovate scalp application combines efficiency with ease of use.
With its active ingredient betamethasone valerate, Betnovate offers powerful anti-inflammatory benefits to ease discomfort.
Now available privately after a convenient consultation with our pharmacist, obtaining Betnovate has never been easier. No longer limited to prescription-only access, the pathway to a healthier scalp is right at your fingertips.
Act now and explore the possibilities that Betnovate scalp application brings. A healthier, happier scalp awaits.
Frequently Asked Questions (FAQs):
Is this an over-the-counter medication?
No, this is a prescription-only-medication that can be purchased over the counter via a private service called PGD (Patient Group Direction).
What will happen once I have answered the questions in the form?
A pharmacist trained to provide this private service will assess the form and call you to discuss the answers you provided with you.
Why do I need to provide my phone number?
In order to dispense this medication without a prescription, the consultation must be carried out via phone or video call. As well as this being a legal requirement to ensure that the medication is suitable for you, the final phone consultation will allow you to ask any questions you may have to the pharmacist.
Is the consultation private?
Patient confidentiality is one of our top priorities, both the form you fill and the phone consultation are strictly confidential between you and the pharmacist.
Do I need to pay for the consultation?
The price you see is inclusive of the consultation fee, so you will not have to pay anything extra.
Active ingredient: Betamethasone Valerate BP 0.122% w/w.
Other ingredients: Carbomer, Isopropyl Alcohol, Sodium Hydroxide, Purified Water.
Usage and Instructions
A small quantity of scalp application should be applied sparingly to the scalp at night and morning until improvement is noticeable. It may then be possible to sustain improvement by applying once a day, or less frequently.
Local Hypersensitivity: Patients with a prior history of sensitivity to corticosteroids should exercise caution when using Betamethasone valerate. The symptoms of local allergic reactions may mimic those of the condition being treated.
Potential Side Effects: In some individuals, overuse of topical steroids like Betamethasone valerate can lead to hypercortisolism (Cushing's syndrome) and reversible disruption of the HPA axis, causing a deficiency in glucocorticosteroids. If these issues arise, reduce the application frequency or switch to a milder steroid. Suddenly stopping the treatment might result in glucocorticosteroid insufficiency.
Risk Factors for Systemic Effects:
- Potency and makeup of the topical steroid
- Length of exposure
- Applying to extensive skin areas
- Enhanced hydration of skin's surface layer
- Use on sealed, thin, or broken skin
- Children may be more at risk due to immature skin and greater surface area relative to body weight
Paediatric Considerations: For children under 12, limit treatment to five days, avoid occlusions, and use long-term corticosteroid therapy sparingly, as it can suppress the adrenal gland.
Infection Risk with Sealing Treatments: Occlusive dressings or skin folds can encourage bacterial infections. Cleanse the skin before applying a new dressing.
Use in Psoriasis: Exercise caution with psoriasis due to potential risks like rebound relapses and tolerance. Close monitoring is essential.
Visual Disturbances: Blurred vision or other visual problems may occur with corticosteroids. Consider referral to an eye specialist if these symptoms present, as they could be signs of cataract, glaucoma, or rare diseases like CSCR.
Scalp Application Instructions: Patients must:
- Keep the product away from the eyes
- Refrain from smoking while using Betnovate scalp application
- Avoid exposure to fire, flame, or heat, including hair dryers, after application
These guidelines ensure safe and effective use of Betnovate scalp application, accommodating various individual needs and potential risks.
|Category||Frequency||Condition or Symptom|
|Infections and Infestations||Very rare||Opportunistic infection|
|Immune System Disorders||Very rare||Hypersensitivity, generalised rash|
|Endocrine Disorders||Very rare||Hypothalamic-pituitary adrenal (HPA) axis suppression, Cushingoid features (e.g. moon face, central obesity), delayed weight gain/growth retardation in children, osteoporosis, glaucoma, hyperglycaemia/glucosuria, cataract, hypertension, increased weight/obesity, decreased endogenous cortisol levels, alopecia, trichorrhexis|
|Skin and Subcutaneous Tissue Disorders||Common||Pruritus, local skin burning /skin pain|
|Very rare||Allergic contact dermatitis /dermatitis, erythema, rash, urticaria, pustular psoriasis, skin thinning / skin atrophy, skin wrinkling, skin dryness, striae, telangiectasias, pigmentation changes*, hypertrichosis, exacerbation of underlying symptoms|
|General Disorders and Administration Site Conditions||Very rare||Application site irritation/pain|
|Eye disorders||Not known||Vision, blurred (see also section 4.4)|
*Skin features secondary to local and/or systemic effects of hypothalamic-pituitary adrenal (HPA) axis suppression.